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Association of enterovirus with dilated
cardiomyopathy and an effective in-vitro
therapeutic strategy against viral infection
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Ratho
Postgraduate Institute of Medical Education and
Research, Chandigarh, India, Chandigarh, India
Background: Enteroviruses (EV) predominantly coxsackievirus
B (CVB), have been implicated as one of the most common eti-
ological agents of dilated cardiomyopathy (DCM). Coxsackievirus
adenovirus receptor (CAR) is recognized as a key determinant for
entry of CVB. Iits genome has been detected in DCM patients.
However, till date no speciﬁc treatment is available for CVB. RNA
interference has evolved as a promising new approach to treat
virus-induced heart diseases. Thus, in the present study we ana-
lyzed prevalence of EV in DCM patients and effect of gene silencing
in-vitro to study the effect on CVB load and CAR expression in CVB
infected cardiomyocytes.
Methods & Materials: Based on echocardiography and
histopathology a total of 22 DCM patients were enrolled. EV
genome was detected in endomyocardial biopsy (EMB) of these
patients by qRT-PCR. The transfection efﬁciency in cardiomyocytes
was determined by ﬂorescentmicroscopy and ﬂow cytometry. CAR
siRNA (Ambion, US) dose dependent inhibition experiments were
done to study cell viability and CAR expression in transfected cells.
Cardiomyocytes were transfected with optimized CAR siRNA for
18h and then infected with 100 m.o.i. of CVB. Cells were harvested
after 24, 48 and 72h interval p.i. for CAR expression and CVB load
and the results were analyzed by paired t-test.
Results: Of the 22 DCM cases, 3 patients died, 18 patients did
not improve and improvement was observed in one patient. 12/18
(66.7%) and 2/3(66.7%) respectivelywere EV positive. Interestingly,
the only patient with improvement was negative for EV. The trans-
fectionwasoptimizedwithanefﬁciencyof>81% incardiomyocytes.
Based on cell viability and CAR expression the CAR siRNA dose was
optimized to be 60pmol. The knockdown of CAR by 60pmol CAR
siRNA in CVB infected cardiomyocytes decreased its expression by
2fold and signiﬁcantly reduced CVB load by 2 log (p<0.05) after
24h p.i.
Conclusion: Thus, EV could be attributed in the pathogenesis of
DCM. Silencing of CAR might be an effective therapeutic approach
against CVB in patients suffering with EV induced DCM.
http://dx.doi.org/10.1016/j.ijid.2014.03.1099
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Molecular epidemiology of enteroviruses
associated with acute encephalitis syndrome in
India
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Sciences, Lucknow-India, Lucknow, India
Background: Enteroviruses (EVs) are RNA viruses in the family
Picornaviridae comprisingmore than100 serotypes that are divided
into four species, human enteroviruses A to D. The clinicalmanifes-
tations of EVs range from conjunctivitis, respiratory tract infection,
myocarditis, meningitis, encephalitis, and neonatal sepsis, like ill-
ness. Encephalitis is a rare presentation of EV infection, but many
EV serotypes (coxsackievirus [CV] A9, A10, and B5, echovirus [ECV]
4, 5, 9, 11, 19, and 30, and EV 71, 75, 76 and 89) have been reported
in encephalitis cases from different parts of the world. Genotyping
of EV is important to establish clinical characteristics and epidemi-
ological link. The objective of this studywas to identify EV serotype
involved in acute encephalitis syndromecases occurred innorthern
India during 2011-2012.
Methods & Materials: Molecular method targeting 5’ untrans-
lated region (UTR) and VP1 capsid regionwas used for EV detection
and identiﬁcation in direct clinical specimen.
Results: EV RNA was detected in 68 (28.7%) of 237 CSF samples
by real time RT-PCR targeting the highly conserved 5’ UTR region.
Molecular typing by RT-PCR and sequencing of a partial VP1 region
revealed the predominance of ECV 19 (n=41), followed by ECV 11
(n=4), EV 76 (n=3), CV B5, ECV 13, 21, EV 69 and EV 101 (n=2
each), CV A2 and ECV 33 (n=1 each). Phylogenetic analysis showed
0-2% divergence at nucleotide level among ECV 19.
Conclusion: ECV 19 was the main etiologic agent involved
in 2011 encephalitis epidemic. Molecular typing of EVs is useful
for characterizing emerging serotypes and their epidemiological
investigation.
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